We’ve been talking about all the potential of mRNA technology — better vaccines and virus detection for all kinds of diseases. Now, let’s talk about the money because the rush is on to invest in mRNA and the whole field of synthetic biology, which approaches the body and natural systems as programmable platforms like computers. However, the history of Silicon Valley and medical tech is mixed. You remember Theranos. Just last week, the founders of a once-hot biotech firm called uBiome were charged with fraud in a similar fashion. Molly speaks with John Cumbers, the founder of SynBioBeta, a network for entrepreneurs, engineers and investors interested in synthetic biology. He says billions of dollars are flowing into the field.